Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001746473-25-000099
Filing Date
2025-05-08
Accepted
2025-05-08 16:16:45
Documents
90
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q plrx-20250331.htm   iXBRL 10-Q 1185055
2 EX-10.1 plrx-20250331xex101.htm EX-10.1 21397
3 EX-31.1 plrx-20250331xex311.htm EX-31.1 9793
4 EX-31.2 plrx-20250331xex312.htm EX-31.2 9760
5 EX-32.1 plrx-20250331xex321.htm EX-32.1 7260
  Complete submission text file 0001746473-25-000099.txt   6582806

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20250331.xsd EX-101.SCH 55221
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plrx-20250331_cal.xml EX-101.CAL 59932
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plrx-20250331_def.xml EX-101.DEF 267750
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20250331_lab.xml EX-101.LAB 648038
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20250331_pre.xml EX-101.PRE 464156
93 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20250331_htm.xml XML 652931
Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39303 | Film No.: 25926391
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)